|This Slide: #59 of 100|
Slide #59. BioReference Laboratories, Inc. — Clinical laboratory in northern California
BioReference Laboratories, Inc. (BRLI)
Clinical laboratory in northern California
BioReference Laboratories, Inc. (Nasdaq:BRLI) announced today that it completed the acquisition of a clinical laboratory in northern California. The Company believes that the California acquisition represents significant strategic value to its national presence, as well as a significant presence in the California market.
Bio-Reference Laboratories is a clinical testing laboratory providing testing, information and related services to physician offices, clinics, hospitals, employers and governmental units. Co. provides a list of laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of diseases. Co. mainly focuses on esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health and correctional health care. Co. also operates a clinical knowledge management service through its PSIMedica business unit, and operates a web-based connectivity portal application through its CareEvolve subsidiary.
Open the BRLI Page at The Online Investor »
Hold (2.00 out of 4)
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite